These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
137 related articles for article (PubMed ID: 16806979)
1. MRI time series modeling of MS lesion development. Meier DS; Guttmann CR Neuroimage; 2006 Aug; 32(2):531-7. PubMed ID: 16806979 [TBL] [Abstract][Full Text] [Related]
2. Progressive gray matter damage in patients with relapsing-remitting multiple sclerosis: a longitudinal diffusion tensor magnetic resonance imaging study. Oreja-Guevara C; Rovaris M; Iannucci G; Valsasina P; Caputo D; Cavarretta R; Sormani MP; Ferrante P; Comi G; Filippi M Arch Neurol; 2005 Apr; 62(4):578-84. PubMed ID: 15824256 [TBL] [Abstract][Full Text] [Related]
3. MRI as an outcome in multiple sclerosis clinical trials. Daumer M; Neuhaus A; Morrissey S; Hintzen R; Ebers GC Neurology; 2009 Feb; 72(8):705-11. PubMed ID: 19073945 [TBL] [Abstract][Full Text] [Related]
4. In vivo assessment of cervical cord damage in MS patients: a longitudinal diffusion tensor MRI study. Agosta F; Absinta M; Sormani MP; Ghezzi A; Bertolotto A; Montanari E; Comi G; Filippi M Brain; 2007 Aug; 130(Pt 8):2211-9. PubMed ID: 17535835 [TBL] [Abstract][Full Text] [Related]
5. Patterns of enhancing lesion evolution in multiple sclerosis are uniform within patients. Minneboo A; Uitdehaag BM; Ader HJ; Barkhof F; Polman CH; Castelijns JA Neurology; 2005 Jul; 65(1):56-61. PubMed ID: 16009885 [TBL] [Abstract][Full Text] [Related]
6. Dynamics of MRI lesion development in an animal model of viral-induced acute progressive CNS demyelination. Pirko I; Gamez J; Johnson AJ; Macura SI; Rodriguez M Neuroimage; 2004 Feb; 21(2):576-82. PubMed ID: 14980559 [TBL] [Abstract][Full Text] [Related]
7. Determinants of disability in multiple sclerosis at various disease stages: a multiparametric magnetic resonance study. Pulizzi A; Rovaris M; Judica E; Sormani MP; Martinelli V; Comi G; Filippi M Arch Neurol; 2007 Aug; 64(8):1163-8. PubMed ID: 17698707 [TBL] [Abstract][Full Text] [Related]
8. T2 MRI texture analysis is a sensitive measure of tissue injury and recovery resulting from acute inflammatory lesions in multiple sclerosis. Zhang Y; Zhu H; Mitchell JR; Costello F; Metz LM Neuroimage; 2009 Aug; 47(1):107-11. PubMed ID: 19361563 [TBL] [Abstract][Full Text] [Related]
9. MRI relapses have significant pathologic and clinical implications in multiple sclerosis. Traboulsee A J Neurol Sci; 2007 May; 256 Suppl 1():S19-22. PubMed ID: 17346748 [TBL] [Abstract][Full Text] [Related]
10. Voxel-based assessment of differences in damage and distribution of white matter lesions between patients with primary progressive and relapsing-remitting multiple sclerosis. Di Perri C; Battaglini M; Stromillo ML; Bartolozzi ML; Guidi L; Federico A; De Stefano N Arch Neurol; 2008 Feb; 65(2):236-43. PubMed ID: 18268194 [TBL] [Abstract][Full Text] [Related]
11. Clinically benign multiple sclerosis despite large T2 lesion load: can we explain this paradox? Strasser-Fuchs S; Enzinger C; Ropele S; Wallner M; Fazekas F Mult Scler; 2008 Mar; 14(2):205-11. PubMed ID: 17986507 [TBL] [Abstract][Full Text] [Related]
12. Brain atrophy evolution and lesion load accrual in multiple sclerosis: a 2-year follow-up study. Tedeschi G; Dinacci D; Comerci M; Lavorgna L; Savettieri G; Quattrone A; Livrea P; Patti F; Morra VB; Servillo G; Orefice G; Paciello M; Prinster A; Coniglio G; Bonavita S; Di Costanzo A; Bellacosa A; Valentino P; Quarantelli M; Brunetti A; Salemi G; D'Amelio M; Simone I; Salvatore M; Bonavita V; Alfano B Mult Scler; 2009 Feb; 15(2):204-11. PubMed ID: 18987104 [TBL] [Abstract][Full Text] [Related]
13. Gray matter atrophy in multiple sclerosis: a longitudinal study. Fisher E; Lee JC; Nakamura K; Rudick RA Ann Neurol; 2008 Sep; 64(3):255-65. PubMed ID: 18661561 [TBL] [Abstract][Full Text] [Related]
14. Evidence for progressive gray matter loss in patients with relapsing-remitting MS. Valsasina P; Benedetti B; Rovaris M; Sormani MP; Comi G; Filippi M Neurology; 2005 Oct; 65(7):1126-8. PubMed ID: 16217074 [TBL] [Abstract][Full Text] [Related]
15. A randomized crossover study of bee sting therapy for multiple sclerosis. Wesselius T; Heersema DJ; Mostert JP; Heerings M; Admiraal-Behloul F; Talebian A; van Buchem MA; De Keyser J Neurology; 2005 Dec; 65(11):1764-8. PubMed ID: 16221950 [TBL] [Abstract][Full Text] [Related]
16. Posterior fossa lesion volume and slowed information processing in multiple sclerosis. Archibald CJ; Wei X; Scott JN; Wallace CJ; Zhang Y; Metz LM; Mitchell JR Brain; 2004 Jul; 127(Pt 7):1526-34. PubMed ID: 15090476 [TBL] [Abstract][Full Text] [Related]
17. Cortical lesions in primary progressive multiple sclerosis: a 2-year longitudinal MR study. Calabrese M; Rocca MA; Atzori M; Mattisi I; Bernardi V; Favaretto A; Barachino L; Romualdi C; Rinaldi L; Perini P; Gallo P; Filippi M Neurology; 2009 Apr; 72(15):1330-6. PubMed ID: 19365054 [TBL] [Abstract][Full Text] [Related]
18. [The role of MRI in the diagnosis and the natural course of multiple sclerosis]. Tourbah A; Lyon-Caen O Rev Neurol (Paris); 2001 Sep; 157(8-9 Pt 1):757-60. PubMed ID: 11677395 [TBL] [Abstract][Full Text] [Related]
19. Vanishing MS T2-bright lesions before puberty: a distinct MRI phenotype? Chabas D; Castillo-Trivino T; Mowry EM; Strober JB; Glenn OA; Waubant E Neurology; 2008 Sep; 71(14):1090-3. PubMed ID: 18824673 [TBL] [Abstract][Full Text] [Related]
20. Different magnetic resonance imaging features in two types of nontraumatic rabbit osteonecrosis models. Takao M; Sugano N; Nishii T; Sakai T; Nakamura N; Yoshikawa H Magn Reson Imaging; 2009 Feb; 27(2):233-9. PubMed ID: 18701230 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]